Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Scheld

Showing results (91-100 of 168) with videos related to

Pageof 17
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 1, 1985
Microbial adhesion to fibronectin in vitro correlates with production of endocarditis in rabbitsW M Scheld, R W Strunk, G Balian, et al.
The Journal of Allergy and Clinical Immunology|September 11, 1992
The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studiesJ M Gwaltney, W M Scheld, M A Sande, et al.
The Journal of Infectious Diseases|October 9, 1999
Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipramG W Sullivan, J Linden, B L Buster, et al.
The American Journal of Medicine|October 19, 1984
Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitisW M Scheld, H Rocha, M A Sande, et al.
The Journal of Clinical Investigation|April 1, 1991
Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factorV J Quagliarello, B Wispelwey, W J Long, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1985
The influence of dosing schedules and cerebrospinal fluid bactericidal activity on the therapy of bacterial meningitisW M Scheld, M G Tauber, O Zak, et al.
The Journal of Clinical Investigation|July 1, 1988
Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the ratA J Lesse, E R Moxon, A Zwahlen, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1987
Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureusW M Scheld, J M Keeley, M R Field, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1982
Clindamycin therapy of experimental Staphylococcus aureus endocarditisW M Scheld, M L Johnson, E B Gerhardt, et al.
The Journal of Infectious Diseases|September 1, 1979
Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenesW M Scheld, D D Fletcher, F N Fink, et al.
Pageof 17

Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 1, 1985
Microbial adhesion to fibronectin in vitro correlates with production of endocarditis in rabbitsW M Scheld, R W Strunk, G Balian, et al.
The Journal of Allergy and Clinical Immunology|September 11, 1992
The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studiesJ M Gwaltney, W M Scheld, M A Sande, et al.
The Journal of Infectious Diseases|October 9, 1999
Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipramG W Sullivan, J Linden, B L Buster, et al.
The American Journal of Medicine|October 19, 1984
Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitisW M Scheld, H Rocha, M A Sande, et al.
The Journal of Clinical Investigation|April 1, 1991
Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factorV J Quagliarello, B Wispelwey, W J Long, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1985
The influence of dosing schedules and cerebrospinal fluid bactericidal activity on the therapy of bacterial meningitisW M Scheld, M G Tauber, O Zak, et al.
The Journal of Clinical Investigation|July 1, 1988
Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the ratA J Lesse, E R Moxon, A Zwahlen, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1987
Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureusW M Scheld, J M Keeley, M R Field, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1982
Clindamycin therapy of experimental Staphylococcus aureus endocarditisW M Scheld, M L Johnson, E B Gerhardt, et al.
The Journal of Infectious Diseases|September 1, 1979
Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenesW M Scheld, D D Fletcher, F N Fink, et al.
Pageof 17